Indian Pharmacopoeia Commission has newly added 19 system suitability/Quantitative impurities for the use of stakeholder
|
Name of Newly Added Impurities |
Lot No. |
Qty |
Rate Per Vial (Private) |
Rate Per Vial (Government) |
|
Norfloxacin Impurity A |
IMP/08/19 |
20mg |
10,000/- |
5,000/- |
|
(+) - Dihydroquinidine |
IMP/09/19 |
20mg |
5,000/- |
2,500/- |
|
Proguanil Hydrochloride Impurity C |
IMP/11/19 |
20mg |
25,000/- |
12,500/- |
|
Lamivudine Impurity A |
IMP/12/19 |
20mg |
25,000/- |
12,500/- |
|
Clotrimazole Impurity B |
IMP/13/19 |
20mg |
10,000/- |
5,000/- |
|
Hydroxychloroquine sulphate |
IMP/14/19 |
20mg |
5,000/- |
2,500/- |
|
Pyridoxine Impurity A |
IMP/15/19 |
20mg |
15,000/- |
7,500/- |
|
Valproic Acid Impurity C |
IMP/16/19 |
20mg |
15,000/- |
7,500/- |
|
Glimepiride Impurity C |
IMP/17/19 |
20mg |
25,000/- |
12,500/- |
|
Etodolac Impurity C |
IMP/18/19 |
20mg |
25,000/- |
12,500/- |
|
Fenofibrate Impurity A |
IMP/12/17 |
20mg |
10,000/- |
5,000/- |
|
Proguanil Hydrochloride Impurity D |
IMP/21/19 |
20mg |
25,000/- |
12,500/- |
|
Rifampicin N-oxide |
IMP/24/19 |
20mg |
10,000/- |
5,000/- |
|
Glimepiride Impurity D |
IMP/23/19 |
20mg |
25,000/- |
12,500/- |
|
Pyridoxine Impurity B |
IMP/20/19 |
20mg |
15,000/- |
7,500/- |
|
Ondenseteron Impurity D |
IMP/19/19 |
20mg |
25,000/- |
12,500/- |
|
Ibuprofen Impurity F |
IMP/22/19 |
20mg |
25,000/- |
12,500/- |
|
Ondenseteron Impurity C |
IMP/10/19 |
20mg |
25,000/- |
12,500/- |
|
Mepyramine Maleate Impurity C |
IMP/14/18 |
20mg |
10,000/- |
5,000/- |